_______________________________________________ Psychedelic Medicine and Interventional Psychiatry
SWTX10PM— 10 CE CREDITS
R elease D ate : 07/01/22
E xpiration D ate : 06/30/25
Psychedelic Medicine and Interventional Psychiatry
Audience The introductory course is designed for psychologists involved in caring for patients with mental disorders resistant to tradi- tional treatment approaches. Course Objective The purpose of this course is to provide psychologists with the knowledge and skills necessary to effectively treat mental disor- ders using emerging psychedelic and interventional techniques. Learning Objectives Upon completion of this course, you should be able to: 1. Outline factors that have contributed to the rise in interest in psychedelic and interventional psychiatry. 2. Define terms related to the discussion of psychedelic and interventional psychiatry. 3. Discuss the history of psychedelics in medical care. 4. Evaluate factors that may impact the provision of psychedelic or interventional psychiatry techniques, including stigma, setting, and culture. 5. Outline the role of psilocybin and ketamine in psychi- atric care. 6. Describe how MDMA and ibogaine may impact men- tal health. 7. Review the clinical effects of kratom, LSD, and mesca- line. 8. Discuss the potential clinical role of nitrous oxide, ayahuasca, and dimethyltryptamine (DMT). 9. Describe how psychedelics may be incorporated into the treatment of mental health disorders, including treatment-resistant depression, post-traumatic stress disorder, and substance use disorders. 10. Identify interventional approaches that may be used in the treatment of mental health disorders.
Faculty Mark S. Gold, MD, DFASAM, DLFAPA , is a teacher of the year, translational researcher, author, mentor, and inventor best known for his work on the brain systems underlying the effects of opiate drugs, cocaine, and food. Dr. Gold was a Professor, Eminent Scholar, Distinguished Professor, Distin- guished Alumni Professor, Chairman, and Emeritus Eminent Scholar during his 25 years at the University of Florida. He was a Founding Director of the McKnight Brain Institute and a pioneering neuroscience-addiction researcher funded by the NIH-NIDA-Pharma, whose work helped to de-stigmatize addic- tions and mainstream addiction education and treatment. He also developed and taught courses and training programs at the University of Florida for undergraduates and medical students. (A complete biography appears at the end of this course.) Faculty Disclosure Contributing faculty, Mark S. Gold, MD, DFASAM, DLFAPA, has disclosed no relevant financial relationship with any prod- uct manufacturer or service provider mentioned. Division Planner James Trent, PhD Senior Director of Development and Academic Affairs Sarah Campbell Division Planner/Director Disclosure The division planner and director have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Accreditations & Approvals As a Jointly Accredited Organization, NetCE is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Educa- tion (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit.
Mention of commercial products does not indicate endorsement.
87
EliteLearning.com/Social-Work
Powered by FlippingBook